2 October 2020

Analgesics Axial spondyloarthritis Biologics Conditions Gout Spondyloarthritis

Europe approves filgotinib despite FDA qualms

7 May 2020

Biologics

Govt relaxes PBS requirements for some medications

30 January 2020

Biologics Communicable Disease Conditions

The long road to RA immunotherapy

30 January 2020

Biologics Conditions Gout

Upadacitinib gets TGA approval

30 January 2020

Biologics Conditions Gout

Let’s not overinterpret febuxostat study, author warns

4 December 2019

Biologics Conditions

Breaking down barriers on medical cannabis

24 October 2019

Analgesics Biologics Conditions

Rivaroxaban twice as likely to lead to clotting

27 August 2019

Ankylosing Spondylitis Biologics Conditions

Almost one-third of RA patients are taking biologics

27 August 2019

Biologics Conditions

Why rheumatic patients stop taking their meds

29 July 2019

Biologics Conditions

Too many elderly still taking too many pills

1 July 2019

Biologics Conditions Juvenile Arthritis

Infection risk rises with glucocorticoid dosage

18 June 2019

Biologics Medications

How would prescribing pharmacists be paid?

23 May 2019

Biologics

Updated guide outlines risks of ‘natural’ interactions

6 May 2019

Biologics

Xeljanz rebate for PsA

16 April 2019

Ankylosing Spondylitis Biologics EULAR

Game-changing RA drugs out of Third World’s reach

16 April 2019

Ankylosing Spondylitis Biologics

Biosimilar launch will make affordable rituximab a reality